Drug development is a notoriously slow, complex and costly process, with over 90% of drug candidates failing before reaching the market. A major cause of this inefficiency is the reliance on ...
Organ-on-a-chip technology has rapidly gained prominence and relevance at the interface between biology and engineering due to its burgeoning potential to revolutionise biomedical research and ...
The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options ...
The liver is accountable for metabolizing most medications and is therefore one of the primary tissues affected by adverse drug reactions. Most classes of medicine can cause drug-induced liver injury ...
A new study provides a powerful way to study infections in environments that closely mimic human organs. The strategy, tested ...
US-based contract research organisation (CRO) PhenoVista Biosciences has entered a collaboration with NETRI, the France-based manufacturer of microfluidic devices for high-throughput screening, to ...
Organ-on-a-chip technology is rapidly changing what is possible with in vitro testing, closely mimicking human biological processes. Andrew Wade spoke with Professor Hazel Screen about its potential ...
Organ-on-Chip market Size, Share, Competitive Landscape and Trend Analysis Report, by Type : Global Opportunity Analysis and industry Forecast, 2020-2030 PORTLAND, OREGON, UNITED STATES, July 15, 2024 ...
Beyond Emulate, CN Bio Innovations has also forged a Cooperative Research and Development Agreement (CRADA) with the FDA, exploring advanced hepatic models through its PhysioMimix platform. In one ...
(MENAFN- GlobeNewsWire - Nasdaq) Join the Lab-on-a-Chip, Microfluidics, Organoids & Organ-on-a-Chip Asia 2025 Conference on October 6-7 at the Nikko Narita, Tokyo-Narita Airport. Network with global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback